探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
Study the early death reason in patients with acute promyelocytic leukemia (APL).
慢性粒细胞白血病进行骨髓移植手术成功率？
Does leukaemia of chronic bead cell undertake medullary transplanting operation is led successfully?
目的观察阻变灵胶囊治疗慢性粒细胞白血病的疗效。
Objective: TO observe the effect of Zubianling capsule in treating chronic myeloid leukemia.
目的了解雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective To further understand the possible mechanism of realgar in the treatment of acute promyelocytic leukemia (APL).
目的了解祛毒化瘀中药复方治疗慢性粒细胞白血病的作用机制。
Objective To study the mechanism of traditional Chinese medicine compound of Qudu Huayu Formula on Chronic Myelocytic Leukemia (CML).
目的：了解慢性粒细胞白血病（CML）患者的血脂变化规律。
Objective:In order to know the alternation of plasma lipids in chronic myelogenous leukemia(CML).
慢性粒细胞白血病CML是造血干细胞的恶性克隆增生性疾病。
Chronic myelocytic leukemia (CML) is the malignant clone disease which occurs in a haematopoietic stem cell.
目的：探讨急性早幼粒细胞白血病（APL）患者早期死亡原因。
Objective:To study the early death reason in patients with acute promyelocytic leukemia (APL).
bcrabl；酪氨酸激酶；抑制剂；慢性粒细胞白血病；综述。
BCRABL; tyrosine kinases; inhibitors; chronic myelogenous leukemia; review.
目的：阐明氧化砷治疗急性早幼粒细胞白血病（APL）的机制。
Objective:To illustrate mechanisms of arsenic trioxide(As2O3) in the treatment of acute promyelocytic leukemia(APL).
目的探讨儿童急性粒细胞白血病(aml)免疫分型及其临床意义。
Objective To explore the immunophenotype of children with acute myeloid leukemia (AML) and its clinical significance.
目的：检测慢性粒细胞白血病（CML）患者血清IL-18水平。
Objective To measure the serum level of interleukin-18(IL-18) in patients with chronic myelocytic leukemia (CML).
P 53基因失活与慢性粒细胞白血病的急变、病情进展密切相关。
The inactivation of P53 is associated with the acute transformation phase and development of CML.
慢性粒细胞白血病是一种造血干细胞克隆性增殖所致的骨髓增殖性疾病。
Chronic myelocytic leukemia is a clonal proliferation of hematopoietic stem cells caused by myeloproliferative disorders.
目的分析急性早幼粒细胞白血病（APL）免疫表型特点及其临床意义。
Objective To investigate the immunophenoytpe of acute promyelocytic leukemia(APL) and its clinical significance.
慢性粒细胞白血病(CML)的PK活性增高，而PK同工酶型均正常。
PK activity was increased in CML, while the PK isoenzyme pattern was normal.
总结分析以清肝化瘀法为主治疗慢性粒细胞白血病5 2例的远期疗效。
To summarize and analyze curative effect on 52 cases of Chronic Myelogenous Leukemia (CML) by clearing away liver fire and dispersing blood stasis.
相关疾病还有一些不涉及BCR-ABL基因的其它类型的慢性粒细胞白血病。
There are other types of CML that do not involve the BCR-ABL gene.
目的揭示急性早幼粒细胞白血病产生维甲酸耐药的机制，探讨耐药性逆转的方法。
Objective to study the mechanism of drug resistance of APL to ATRA and the methods of reversion.
同时，在慢性粒细胞白血病治疗方面，另两个采用类似基因治疗的研究也收获成果。
Two other studies, meanwhile, confirmed that a similar approach to chronic myelogenous leukaemia continues to bear fruit.
慢性中性粒细胞白血病和慢性淋巴细胞白血病均未发现CD 133的阳性表达。
There were no expression of CD133 in chronic neutrophilic leukemia (CNL) and chronic lymphocytic leukemia (CLL) patients.
在高浓度，筹备工作已经表明，以抑制急性淋巴细胞白血病和急性粒细胞白血病细胞。
In high concentrations, preparations have shown to inhibit cells from acute lymphocytic and acute granulocytic leukemia.
目的：研究复方青黛片的主要成分雄黄治疗急性早幼粒细胞白血病（APL）的机制。
Objective: To study the possible mechanism of red orpiment, which is main component of composite indigo naturalis tablets, in the treatment of acute promyelocytic leukemia(APL).
目的为了解慢性粒细胞白血病（CML）骨髓中巨核细胞和网状纤维的增生情况及其关系。
Objective To determine the distribution of reticulin fibre and megakaryocyte in bone marrow biopsy(Trephine biopsy)of chronic myelogenous leukemia (CML).
丙卡巴肼、氮芥和异环磷酰胺：可增加患骨髓增生异常综合症和急性粒细胞白血病的风险。
Procarbazine, nitrogen mustard, and ifosfamide, which can increase risk for myelodysplastic syndromes and acute myelogenous leukemia.
靶向过氧化物酶I/II，一种天然二帖类物质，诱导分化和根除急性早幼粒细胞白血病。
Targeting peroxiredoxin I/II by Adenanthin, a naturally occurring diterpenoid, to induce differentiation and eradicate leukemia-initiating cells of acute promyelocytic leukemia.
风险随着时间的推移逐渐下降，这样的累积粒细胞白血病过剩风险已不再显着于期末的后续行动。
Risks declined steadily over time, such that the cumulative excess risk of myeloid leukemia was no longer statistically significant at the end of the follow-up period.
目的：探讨慢性粒细胞白血病（CML）患者BCR/ABL融合基因表达与中医辨证分型的关系。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).
目的：探讨慢性粒细胞白血病（CML）患者BCR/ABL融合基因表达与中医辨证分型的关系。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML).
应用推荐